TheraRadar

Pharma Intelligence, Simplified

← All Targets

ribonucleotide reductase

1 drugs
1
Approved Drugs
1
Companies
0
Indications
0
Therapeutic Areas
Unlock Full Target Intelligence PRO
Competitive landscape by company (1 companies)
All 1 approved drugs
Therapeutic area breakdown
Full indication list (0 indications)
Patent cliff analysis
Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo

Drugs by Company

Hikma 1 drug

By Therapeutic Area

Other 1 drugs